Drug
ME 401
ME 401: highest development phase Phase 2, developed by Kyowa Kirin. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Kyowa Kirin
Trials
| Drug | Phase | Indication |
|---|---|---|
| ME-401 NCT04533581 | Phase 2 | Indolent B-cell Non-Hodgkin's Lymphoma |
| ME-401 NCT03985189 | Phase 1 | Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma |
Latest
No recent events.
Follow ME 401 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.